Improving the methods for evaluating the safety of psychotropic medications in children and adolescents

Current Therapeutic Research - Clinical and Experimental

Volumn 62, Issue 12, 2001, Pages 873-884

  Greenhill, Laurence L ^a   Vitiello, Benedetto ^b   Abikoff, Howard ^c   Levine, Jerome ^d   March, John S ^e   Riddle, Mark A ^f   Capasso, Lisa ^a   Cooper, Thomas ^d   Davies, Mark ^a   Fisher, Prudence ^a   Findling, Robert L ^g   Fried, Jane ^a   Labellarte, Michael ^f   McCracken, James ^h   McMahon, Donald J ^d   Robinson, James ^d   Skrobala, Anne M ^a   Scahill, Lawrence ⁱ   Walkup, John ^f   Zito, Julie ^j  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^e DUKE UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF MARYLAND   (United States)

more..

Author keywords

Adverse events; Children; Drug safety; Psychopharmacology; Treatment

Indexed keywords

NEUROTRANSMITTER; PSYCHOTROPIC AGENT;

ADOLESCENT; ANALYTIC METHOD; CHILD; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; FOLLOW UP; GROWTH RATE; HUMAN; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL ANALYSIS;

EID: 0035699362     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(01)80092-8     Document Type: Conference Paper

References (40)

1. Changing patterns of psychotropic medications prescribed by child psychiatrists in the 1990s
2. Trends in the prescribing of psychotropic medications to preschoolers
3. Developmental perspectives in pediatric psychopharmacology
4. Medication development and testing in children and adolescents. Current problems, future directions
5. Are stimulants overprescribed? Treatment of ADHD in 4 U.S. communities
6. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline
7. Post-marketing surveillance of drugs
8. The spontaneous reporting system in the United States
9. A double-blind, placebo-controlled study of modified-release MPH MR in children with attention-deficit/hyperactivity disorder
10. Randomized controlled trial of OROS methylphenidate Q.D. in children with attention-deficit/hyperactivity disorder
11. Another sudden death in a child treated with desipramine
12. Case study: Adverse response to clonidine
13. Pemoline-associated fulminant liver failure: Testing the evidence for causation
14. Pemoline hepatotoxicity and postmarketing surveillance
15. Case study: Risperidone-induced hepatotoxicity in pediatric patients
16. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy
17. Phenobarbital for febrile seizures - Effects on intelligence and on seizure recurrence
18. Lamotrigine. A review of its use in childhood epilepsy
19. Valproic acid hepatic fatalities: A retrospective view
20. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women
21. Convergence and plasticity of monoaminergic systems in the medial prefrontal cortex during the postnatal period: Implications for the development of psychopathology
22. Long-term effects of stimulant medication on the brain: Possible relevance to the treatment of ADHD
23. Growth deficits in ADHD children revisited: Evidence for disorder-associated growth delays
24. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: A prospective study
25. Ascertainment of side effects in psychopharmacologic clinical trials
26. SAFTEE: A technique for the systematic assessment of side effects in clinical trials
27. Rating scales and assessment instruments for use in pediatric psychopharmacology research
28. Adverse events
29. Pharmacotherapy for children with attention-deficit hyperactivity disorder
30. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systematic placebo-controlled evaluation
31. General versus systematic inquiry about emergent clinical events with SAFTEE: Implications for clinical research
32. Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA Titration Trial
33. Methylphenidate effects on children with attention deficit hyperactivity disorder: Self-report of symptoms, side-effects and self-esteem
34. Making medicines safer - The need for an independent drug safety board